revvity.com - Wutah dodolan YoY sajrone rolas wulan kepungkur RVTY

The 12-month sales dynamics history year-over-year for Revvity, Inc. (RVTY) reflects market expectations, where 4.50 represents the current metric level. Growth is driven by the implementation of AI screening and genomic technologies. Partnerships with biopharma centers to accelerate drug development further bolster this positive outlook. A diversified global supply network for reagents and diagnostic equipment ensures the business's stability.
Revvity Corp - rincian analitis lan metrik utama (RVTY)

The scale of Revvity, Inc. (RVTY) expansion into the high-margin software and reagents segment is clearly reflected in the TTM revenue growth rates compared to last year. This indicator measures the percentage change in total revenue over a rolling year, allowing investors to assess the sustainability of the business model and the risk of asset overvaluation should the organic expansion of the company's laboratory ecosystem slow down.